Sarepta Therapeutics to Announce Third Quarter 2023 Financial Results
25 Octobre 2023 - 2:30PM
Business Wire
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in
precision genetic medicine for rare diseases, will report third
quarter 2023 financial results after the Nasdaq Global Market
closes on Wednesday, Nov. 1, 2023. Subsequently, at 4:30 p.m. E.T.,
the Company will host a conference call to discuss its third
quarter 2023 financial results.
The event will be webcast live under the investor relations
section of Sarepta's website at
https://investorrelations.sarepta.com/events-presentations
and following the event a replay will be archived there for one
year. Interested parties participating by phone will need to
register using this online form. After registering for
dial-in details, all phone participants will receive an
auto-generated e-mail containing a link to the dial-in number along
with a personal PIN number to use to access the event by phone.
About Sarepta Therapeutics Sarepta is on an urgent mission:
engineer precision genetic medicine for rare diseases that
devastate lives and cut futures short. We hold leadership positions
in Duchenne muscular dystrophy (DMD) and limb-girdle muscular
dystrophies (LGMDs), and we currently have more than 40 programs in
various stages of development. Our vast pipeline is driven by our
multi-platform Precision Genetic Medicine Engine in gene therapy,
RNA and gene editing. For more information, please visit
www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and
Facebook.
Internet Posting of Information We routinely post information
that may be important to investors in the 'For Investors' section
of our website at www.sarepta.com. We encourage investors and
potential investors to consult our website regularly for important
information about us.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231025578048/en/
Investor Contact: Ian Estepan, 617-274-4052
iestepan@sarepta.com
Media Contact: Tracy Sorrentino, 617-301-8566
tsorrentino@sarepta.com
Sarepta Therapeutics (NASDAQ:SRPT)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Sarepta Therapeutics (NASDAQ:SRPT)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024